RETRACTION: Reduced miR-202 levels enhanced oral cancer development via targeting Sp1 (Retraction of Vol 18, Pg 489, 2019)

被引：0

|

作者：

Zhao, Jia

Ding, Deguang

Zhao, Ge

机构：

来源：

EXPERIMENTAL AND THERAPEUTIC MEDICINE | 2024年 / 27卷 / 06期

关键词：

D O I：

10.3892/etm.2024.12539

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[1] Reduced miR-202 levels enhanced oral cancer development via targeting Sp1
Zhao, Jia
Ding, Deguang
Zhao, Ge
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 489 - 496
[2] RETRACTION: miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3 (Retraction of Vol 16, Pg 2281, 2017)
Zhao, Zhonghai
Lv, Bin
Zhang, Li
Zhao, Nana
Lv, Yan
MOLECULAR MEDICINE REPORTS, 2022, 26 (04)
[3] RETRACTION: Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 (Retraction of Vol 13, Pg 6709, 2020)
Yang, J.
Li, B.
Zhao, S.
Du, H.
Du, Y.
ONCOTARGETS AND THERAPY, 2021, 14 : 123 - 123
[4] RETRACTION: MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro (Retraction of Vol 18, art no 1533033819871300, 2019)
Li, H.
Zhang, X.
Jin, Z.
Yin, T.
Duan, C.
Sun, J.
Xiong, R.
Li, Z.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
[5] MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1 (vol 51, pg 598, 2019)
Lin, Yilin
Chen, Zhihua
Lin, Suyong
Zheng, Yan
Liu, Yisu
Gao, Ji
Chen, Shaoqin
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (12) : 1305 - 1306
[6] RETRACTION: miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 (Retraction of Vol 12, Pg 2719, 2020)
Bai, P.
Li, W.
Wan, Z.
CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12581 - 12581
[7] RETRACTION: Statement of Retraction: miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1 (Retraction of Vol 18, Pg 333, 2019)
Zhou, Jian
Zhang, Ying
Han, Zhaofeng
Dong, Zhiwei
Cao, Tongtong
Wei, Aizhou
Guo, Pengfei
Meng, Qingnan
CELL CYCLE, 2023, 22 (06) : 734 - 734
[8] RETRACTION: MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5 (Retraction of Vol 23, Pg 6436, 2019)
Sun, C. -M.
Zhang, G. -M.
Qian, H. -N.
Cheng, S. -J.
Wang, M.
Liu, M.
Li, D.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (13) : 4439 - 4439
[9] RETRACTION: MiR-650 regulates the proliferation, migration and invasion of human oral cancer by targeting Growth factor independent 1 (Gfi1) (Retraction of Vol 156, Pg 69, 2019)
Sun, Ningning
Sun, Libo
Wu, Chuanbin
Sun, Haijiang
Qing, Zhou
BIOCHIMIE, 2023, 204 : 171 - 171
[10] RETRACTION: miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66 (Retraction of Vol 18, art no 1533033819870209, 2019)
Ma, Xiao
Li, Dan
Gao, Yan
Liu, Cheng
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20

← 1 2 3 4 5 →